ArticleBMC endocrine disorders2019

Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study.

Laura J Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.